Health Results Based Financing Impact Evaluation 2018, Health Facility Midline Survey
Congo, Dem. Rep., 2018
Get MicrodataCreated on
Mar 22, 2021
Last modified
Mar 22, 2021
Page views
66570
964 Rifampicine+Isoniazide+Pyrazinamide (Q14_18_74)
Data file: f1_facility.dta
Overview
Valid:
176
Invalid:
33
Minimum:
0
Maximum:
800
Type:
Discrete
Decimal:
0
Start:
7028
End:
7030
Width:
3
Range:
0 - 800
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0 | 161 |
91.5%
|
|
| 3 | 1 |
0.6%
|
|
| 12 | 1 |
0.6%
|
|
| 20 | 1 |
0.6%
|
|
| 28 | 1 |
0.6%
|
|
| 50 | 1 |
0.6%
|
|
| 83 | 1 |
0.6%
|
|
| 84 | 2 |
1.1%
|
|
| 96 | 1 |
0.6%
|
|
| 168 | 1 |
0.6%
|
|
| 246 | 1 |
0.6%
|
|
| 480 | 1 |
0.6%
|
|
| 512 | 1 |
0.6%
|
|
| 670 | 1 |
0.6%
|
|
| 800 | 1 |
0.6%
|
|
| Sysmiss | 33 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.